Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Suresh Jadhav (biotechnology executive)
Suresh Jadhav | |
|---|---|
&sq=&lang=en&file=File:Suresh_Jadhav_for_Doctors_Without_Borders.jpg) Jadhav in a 2013 video for Doctors Without Borders | |
| Born | 1948 or 1949 |
| Died | 7 December 2021 (aged 72) Pune, Maharashtra, India |
| Occupation | Biotechnology executive |
Suresh Jadhav (1948/49 – 7 December 2021) was an Indian biotechnology executive and a key member of the Indian vaccine manufacturing industry.[1] At the Serum Institute of India (SII) he led the development and introduction of the Meningococcal A conjugate vaccine to Sub-Saharan Africa and the production of the COVID-19 vaccine at SII, including the ones marketed as Covishield.
Jadhav was a member of the board of the GAVI vaccine alliance, and a member of the Indian government's expert committee on vaccines and other biologicals and a member of the Indian Pharmacopoeia Commission.
Previous Page Next Page
